The analysis of the immune microenvironment in this study showed that the expression level of CMTM1/2/3/6 had a certain correlation with the infiltration of a variety of immune cells (B cells, macrophages, neutrophils, dendritic cells, and CD4+ cells) in ovarian cancer (Figure 8A). This evidence concerns the gene CD4 and ovarian carcinoma.